These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
545 related items for PubMed ID: 15569919
1. Interferon for hepatitis C patients with psychiatric disorders. Rifai MA, Bozorg B, Rosenstein DL. Am J Psychiatry; 2004 Dec; 161(12):2331-2; author reply 2332-4. PubMed ID: 15569919 [No Abstract] [Full Text] [Related]
2. Interferon for hepatitis C patients with psychiatric disorders. Asnis GM, De La Garza R, Rego SA, Henderson MA, Reinus JF. Am J Psychiatry; 2004 Dec; 161(12):2332; author reply 2332-4. PubMed ID: 15569920 [No Abstract] [Full Text] [Related]
3. [Genotype 1 superresponder treat for only 24 weeks]. MMW Fortschr Med; 2005 Dec 15; 147(51-52):69. PubMed ID: 16402717 [No Abstract] [Full Text] [Related]
4. Interferon for hepatitis C patients with psychiatric disorders. Wilson MS. Am J Psychiatry; 2004 Dec 15; 161(12):2332; author reply 2332-4. PubMed ID: 15569921 [No Abstract] [Full Text] [Related]
5. [Antiviral therapy of patients with chronic hepatitis C with normal level of aminotransferases]. Lopukhova NL. Eksp Klin Gastroenterol; 2007 Dec 15; (4):146-52. PubMed ID: 18409502 [No Abstract] [Full Text] [Related]
6. [Pegylated-interferon alpha plus ribavirin-induced subacute thyroiditis in chronic hepatitis C]. Abellán Galiana P, Pérez-Lázaro A, Aguilera Sancho-Tello V, Merino Torres JF, Berenguer Haym M, Piñón Sellés F. Endocrinol Nutr; 2009 Mar 15; 56(3):136-9. PubMed ID: 19627727 [Abstract] [Full Text] [Related]
7. [APRICOT Study evaluated. Surprisingly high virologic response in HIV-HCV coinfection]. MMW Fortschr Med; 2004 Apr 26; 146 Spec No 1():74-5. PubMed ID: 15373058 [No Abstract] [Full Text] [Related]
8. Peginterferon and ribavirin for chronic hepatitis C. Hoofnagle JH, Seeff LB. N Engl J Med; 2006 Dec 07; 355(23):2444-51. PubMed ID: 17151366 [No Abstract] [Full Text] [Related]
9. Peginterferon- and ribavirin-induced bipolar episode successfully treated with lamotrigine without discontinuation of antiviral therapy. Navinés R, Castellví P, Solà R, Martín-Santos R. Gen Hosp Psychiatry; 2008 Dec 07; 30(4):387-9. PubMed ID: 18585548 [No Abstract] [Full Text] [Related]
11. A change of peginterferon may permit continuation of antiviral therapy in hepatitis C virus-infected patients with interstitial pneumonitis. Shimada M, Yoshida S, Kornek M, Kim SJ, Schuppan D. Liver Int; 2010 Nov 09; 30(10):1552-4. PubMed ID: 20557455 [No Abstract] [Full Text] [Related]
12. [Effectiveness and safety of antiviral therapy of military personnel suffering from chronic hepatitis C]. Zhdanov KV, Gusev DA, Kozlov KV, Shishkin MK, Sukachev VS, Shakhmanov DM, Zhabrov SS. Voen Med Zh; 2015 Apr 09; 336(4):44-9. PubMed ID: 26454938 [Abstract] [Full Text] [Related]
16. Hepatitis C virus therapy to date. Foster G, Mathurin P. Antivir Ther; 2008 May 29; 13 Suppl 1():3-8. PubMed ID: 18432157 [Abstract] [Full Text] [Related]
17. Summaries for patients. Re-treating patients with chronic hepatitis C who have not responded to peginterferon-alpha2b. Ann Intern Med; 2009 Apr 21; 150(8):I-34. PubMed ID: 19380849 [No Abstract] [Full Text] [Related]
18. Hepatitis C treatment, HAART and side effects. TreatmentUpdate; 2001 Apr 21; 13(7):7-8. PubMed ID: 11794865 [No Abstract] [Full Text] [Related]
19. Catatonia associated with pegylated interferon-α 2b and ribavirin for hepatitis C. Quinn D, Kuchler E, Deming P, Arora S. Psychosomatics; 2012 Apr 21; 53(4):400-1. PubMed ID: 22748752 [No Abstract] [Full Text] [Related]
20. [Combination therapy for chronic viral hepatitis C]. Zeuzem S. Dtsch Med Wochenschr; 2003 Feb 21; 128(8):370-4. PubMed ID: 12594622 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]